Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XT1061 in chronic hepatitis B (Ib/IIa, multiple dosing)
CTR20260401Phase 2Active
- Sponsor
- Xi'an Xintong Pharmaceutical Research Co., Ltd.
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of XT1061 in Chronic Hepatitis B (CHB), sponsored by Xi'an Xintong Pharmaceutical Research Co., Ltd.. Started Feb 2026; status: active.
02
Drugs
XT1061
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20260401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260401.